Kim Kelderman insider trades: BIO-TECHNE (TECH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kim reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | TECH | ↓ Sell | 13,392 | $77.29 | $1.0M | Direct | Jan 29, 2025 (2d) |
| Nov 19, 2021 | TECH | ↓ Sell | 500 | $505.38 | $253K | Direct | Nov 23, 2021 (4d) |
| Sep 22, 2021 | TECH | ↓ Sell | 822 | $529.04 | $435K | Direct | Sep 24, 2021 (2d) |
| Jun 9, 2021 | TECH | ↓ Sell | 811 | $433.00 | $351K | Direct | Jun 11, 2021 (2d) |
| May 25, 2021 | TECH | ↓ Sell | 845 | $424.00 | $358K | Direct | May 27, 2021 (2d) |
| Feb 5, 2021 | TECH | ↓ Sell | 823 | $388.45 | $320K | Direct | Feb 9, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TECH insiders
Open-market trades in the last 12 months
About Kim Kelderman's insider trades
Kim Kelderman is Chief Executive Officer at BIO-TECHNE (TECH). Since Feb 5, 2021, Kim has reported no open-market purchases and 6 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (20 filings), shares withheld for taxes (17 filings), grants and awards (14 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TECH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.